Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT in connection with sale of Swedegas
Mandate

Vinge advises EQT in connection with sale of Swedegas

March 23, 2015

Vinge advises EQT Infrastructure in connection with the sale of Swedegas to a consortium of Enagás Internacional S.L.U., part of Spain’s leading natural gas transmission company Enagás S.A., and Fluxys Europe B.V., part of the Belgium-based natural gas infrastructure group Fluxys SA. Swedegas owns and operates Sweden’s entire gas transmission network, extending from Dragör in Denmark to Stenungsund in Sweden. The transaction is expected to close in mid-April.

Vinge’s team consists of responsible partner Daniel Rosvall together with Matthias Pannier and Oscar Rydén (corporate), Carl Johan af Petersens, Johan Cederblad and Helena Wanhainen (regulatory).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026